ADH1A and hepatocellular carcinoma: In order to rule out that changes in the expression pattern of ADH1A and ALDH2 during HCC onset and progression is due to genetic mutations, we checked their mutation level in HCC patients and found that these genes are mutated in <2% of HCC patients from TCGA database (Figure 4I).